The Trouble With a Premature Vaccine

What happens to the global economy if the medicine ends up harming those it’s meant to cure?

Hope is beginning to fade that the world will have a safe and effective coronavirus vaccine before the predicted “second wave” arrives that will further suppress economic activity and recovery. Despite an unprecedented global effort, a deliverable vaccine might still be months away. Almost certainly it won’t be ready by October as many hoped. Dr. Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases, said November or December would be more realistic. It is understandable that governments and politicians are trying to be optimistic. The global economy was pummeled in the first wave, and it is hardly in shape to receive another devastating blow if the second wave materializes and lockdowns are reinstated. As economies open back up, some countries that were able to control the spread of the virus are now experiencing a resurgence of cases. In France and Spain, for example, the number of new infections is higher now than it was in March during the peak of the first wave. Failure to control the coronavirus has put economies and political careers in jeopardy. It’s little wonder why President Donald Trump is under enormous pressure to have a vaccine shipped before Election Day in […]

Subscribe to Geopolitical Futures today and get:

  • Unbiased analysis of global events
  • Daily geopolitical briefing
  • Annual and long-term forecasts to help you prepare for your future
Subscription Options
Alex Berezow
Alex Berezow joins Geopolitical Futures to analyze the impact of science, technology, and public health on geopolitics. Dr. Berezow is a prolific science writer who has written over 1,000 articles, many of which appeared in major news outlets. He is also a monthly columnist for the Puget Sound Business Journal and a member of the USA Today Board of Contributors. Currently, Dr. Berezow is also Vice President of Scientific Communications at the American Council on Science and Health, a consumer advocacy non-profit whose mission is to debunk “junk science,” promote evidence-based policy, and separate exaggerated health scares from legitimate health threats. He is also a Non-Resident Fellow at the Council on Strategic Risks. Previously, he was founding editor of RealClearScience (of the RealClearPolitics family of websites), and he served as assistant editor of RealClearWorld, where he specialized in European affairs. Dr. Berezow holds a PhD in microbiology from the University of Washington.